Đang chuẩn bị liên kết để tải về tài liệu:
Insulin-like growth factor-1 signaling in renal cell carcinoma
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Renal cell carcinoma (RCC) incidence is highest in highly developed countries and it is the seventh most common neoplasm diagnosed. RCC management include nephrectomy and targeted therapies. Type 1 insulin-like growth factor (IGF-1) pathway plays an important role in cell proliferation and apoptosis resistance. IGF-1 and insulin share overlapping downstream signaling pathways in normal and cancer cells. |